Replimune (REPL) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

REPL Replimune

Watchlist

13.260
-1.670-11.19%

Close Nov 25 16:00 ET

13.300
+0.040+0.30%

Post 19:15 ET

907.22MMarket Cap-4361P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Reported Earlier, Replimune Prices $140M Upsized Public Offering Of 6,923,000 Common Shares At $13/Share
Benzinga56minutes ago
Replimune Expects Gross Proceeds From Offering to Be Approximately $140M>REPL
Dow Jones00:01 ET
Replimune Announces Pricing of 6.9M Shares of Common Stock at $13.00 Each >REPL
Dow Jones00:01 ET
Replimune Expects Offering to Close Nov. 27>REPL
Dow Jones00:01 ET
Replimune Announces Pricing of Upsized Public Offering
GlobeNewswire23:55 ET
Express News | Corrected-Buzz-U.S. Stocks on the Move-AMC, Alnylam, Super Micro
Reuters11:34 ET

Comments

Kevin Travers

Nov 22 15:03

Columns Friday Market Climbs | Wall Street Today

The market climbed Friday after a week of waiting and reacting to Nvidia earnings and Bitcoin's all-time highs.
The market overall advanced Friday. Just past 4 pm ET the $S&P 500 Index (.SPX.US)$ traded +0.35%, the $Dow Jones Industrial Average (.DJI.US)$ climbed 0.97%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 0.16%.
MACRO
In macroeconomics, S&P Global released its composite and service PMI. Composite came in at a two-year high, 55.3...

Weekly Buzz

Kevin Travers

Nov 22 10:06

Columns Market Climbs, Bitcoin Close to $100k | Live Stock

Good morning, traders. Happy Friday, November 22nd. Without the news and animal spirits moving markets, you will not make it through today. My name is Kevin Travers, and the S&P 500 and market climbed this morning, here is what's moving:
$Super Micro Computer (SMCI.US)$ climbed 15%, after earlier this week, the firm said it submitted a plan to release its six-month delayed 10k with a new auditor, BDO USA, and filed for a time extension to file it...

Bitcoin ups and downs: How far is it from $100,000?

Jaguar8

Nov 22 08:40

😍😍😍

$Replimune (REPL.US)$

Jaguar8

Nov 21 22:29

On watchlist. Reason: Breakthrough Therapy Designation + Biologics License Application in Accelerated pathway for Melanoma. News after hours

$Replimune (REPL.US)$

Trytosaveabit

Nov 21 15:09

News

$Replimune (REPL.US)$ Reuters· 3 mins ago
Replimune Receives Breakthrough Therapy Designation for Rp1 and Submits Rp1 Biologics License Application to the FDA Under the Accelerated Approval Pathway